Loading...
research article
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
Recent studies have demonstrated that combined substitutions of rifapentine for rifampin and moxifloxacin for isoniazid in the standard, daily, short-course regimen of rifampin, isoniazid, and pyrazinamide produces stable cure in 12 weeks or less. This study was designed to more precisely evaluate the contribution of moxifloxacin and isoniazid to rifapentine-based regimens.
Type
research article
Authors
Publication date
2008
Volume
178
Issue
9
Start page
989
End page
93
Peer reviewed
NON-REVIEWED
EPFL units
Available on Infoscience
April 27, 2012
Use this identifier to reference this record